The Kickback: Insurer Payments To Docs
2 CommentsBy Ed Silverman // August 2nd, 2007 // 11:40 pm
Actually, there’s nothing new about managed care offering incentives to docs to lower costs and improve health outcomes. But a Boston television station ran a segment this week raising this question: is it ethical for docs to receive a payment for switching a patient from, say, Lipitor to generic Zocor if the patient isn’t informed? What do you think? Watch the segment and then answer our poll below…
Should the drugmakers have waited to release the SEAS results?
- No (73%, 82 Votes)
- Yes (27%, 31 Votes)
Total Voters: 113
Loading ...
Hank
directly related to last exchange, and featuring our beloved BCN of Mich.
AJP
All participants in the healthcare model should be “at risk”. Risk models are the ultimate level playing field.The patient is at risk for falling in the donut whole for over use of brand products , MD are at risk b/c it comes out of their overall PMPM compensation and and insurers are at risk for overall cost of products. Risk behooves all! Finally tell all what the cost of product really cost , without rebates and the like. Upfront in your face cost and let all player in the healthcare system what behooves them!!